Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2016

01-09-2016 | Editorial

Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks?

Authors: Tilak Shah, Alvin Zfass, Mitchell L. Schubert

Published in: Digestive Diseases and Sciences | Issue 9/2016

Login to get access

Excerpt

Although controversy has surrounded the existence and function of the sphincter of Oddi (SO) since its initial description by Rugero Oddi in 1887, animal studies, and to a lesser extent human studies, have subsequently confirmed its existence and clarified the important anatomic and physiologic functions of the sphincter [1]. The SO, located at the distal extremity of the bile and pancreatic ducts, is comprised of tonically active smooth muscle that controls the flow of bile and pancreatic juice into the second portion of the duodenum. During feeding, cholecystokinin (CCK) as well as other hormones and neurally mediated reflexes stimulate gallbladder contraction and pancreatic secretion as well as relax the SO. This coordinated activity enables bile and pancreatic secretions to enter the duodenal lumen in order to facilitate digestion and absorption [2]. …
Literature
2.
go back to reference Behar J, Biancani P. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action. J Clin Invest. 1980;66:1231–1239.CrossRefPubMedPubMedCentral Behar J, Biancani P. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action. J Clin Invest. 1980;66:1231–1239.CrossRefPubMedPubMedCentral
3.
go back to reference Worthley CS, Baker RA, Iannos J, et al. Human fasting and postprandial sphincter of Oddi motility. Br J Surg. 1989;76:709–714.CrossRefPubMed Worthley CS, Baker RA, Iannos J, et al. Human fasting and postprandial sphincter of Oddi motility. Br J Surg. 1989;76:709–714.CrossRefPubMed
6.
go back to reference Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320:82–87.CrossRefPubMed Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320:82–87.CrossRefPubMed
7.
go back to reference Wehrmann T, Wiemer K, Lembcke B, et al. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol. 1996;8:251–256.CrossRefPubMed Wehrmann T, Wiemer K, Lembcke B, et al. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol. 1996;8:251–256.CrossRefPubMed
8.
go back to reference Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311:2101–2109.CrossRefPubMedPubMedCentral Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311:2101–2109.CrossRefPubMedPubMedCentral
9.
go back to reference Pauls QI, Durkalski-Mauldin V, Brawman-Mintzer O, et al. Duloxetine for the treatment of patients with suspected sphincter of Oddi dysfunction. Dig Dis Sci. (Epub head of print). doi:10.1007/s10620-016-4187-1. Pauls QI, Durkalski-Mauldin V, Brawman-Mintzer O, et al. Duloxetine for the treatment of patients with suspected sphincter of Oddi dysfunction. Dig Dis Sci. (Epub head of print). doi:10.​1007/​s10620-016-4187-1.
10.
go back to reference Rahimi R, Nikfar S, Rezaie A, et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2009;15:1548–1553.CrossRefPubMedPubMedCentral Rahimi R, Nikfar S, Rezaie A, et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2009;15:1548–1553.CrossRefPubMedPubMedCentral
11.
go back to reference Cotton PB, Elta GH, Carter CR, et al. Rome IV. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;16:S0016–5085. Cotton PB, Elta GH, Carter CR, et al. Rome IV. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;16:S0016–5085.
Metadata
Title
Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks?
Authors
Tilak Shah
Alvin Zfass
Mitchell L. Schubert
Publication date
01-09-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4252-9

Other articles of this Issue 9/2016

Digestive Diseases and Sciences 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.